Revance Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
ALKERMES USD 1.51B 46.61M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
J&J USD 78.11B 6.62B 2025-03
Merck USD 48.34B 2.02B 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
P&G USD 52.27B 829M 2025-03
Pacira USD 798.54M 20.19M 2025-03
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12



Revance Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.